IP Library Granted Patent US 8,119,772
Granted Patent B2
US 8,119,772 · App. 11/864,841 · Granted Feb 21, 2012

MART-1 T cell receptors

Assignees: California Institute of Technology; Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,772
App. No.
11/864,841
Granted
Feb 21, 2012
Kind
B2
Abstract

T-cell receptors that recognize MART-1 antigen are provided. The TCRs can be used, for example, to treat patients suffering from melanoma.

Claims (18)

1. An isolated polypeptide comprising an amino acid sequence with at least 95% sequence identity to SEQ ID NO: 3, wherein the variable region of the polypeptide consists of SEQ ID NO: 4.

2. The isolated polypeptide of claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 3.

3. A transfected cell comprising:

a T-cell receptor comprising an α subunit with at least 95% sequence identity to SEQ ID NO: 3 and a β subunit with at least 95% sequence identity to SEQ ID NO:7, wherein the variable region of the α subunit consists of SEQ ID NO: 4, and wherein the variable region of the β subunit consists of SEQ ID NO: 8.

4. A T-cell receptor, comprising:

an α subunit; and

a β subunit,

wherein the α subunit comprises an amino acid sequence with at least 95% sequence identity to SEQ ID NO: 3 and the β subunit comprises an amino acid with at least 95% sequence identity to SEQ ID NO:7, wherein the variable region of the α subunit consists of SEQ ID NO: 4, and wherein the variable region of the β subunit consists of SEQ ID NO: 8.

5. The isolated polypeptide of claim 1 , wherein the polypeptide comprises an amino acid sequence with at least 99% sequence identity to SEQ ID NO: 3.

6. The isolated polypeptide of claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO: 3.

7. The transfected cell of claim 3 , wherein the α subunit has at least 99% sequence identity to SEQ ID NO: 3.

8. The transfected cell of claim 3 , wherein the α subunit consists of the amino acid sequence of SEQ ID NO: 3.

9. The transfected cell of claim 3 , wherein the β subunit has at least 99% sequence identity to SEQ ID NO:7.

10. The transfected cell of claim 3 , wherein the β subunit consists of the amino acid sequence of SEQ ID NO: 7.

11. The T-cell receptor of claim 4 , wherein the α subunit has at least 99% sequence identity to SEQ ID NO: 3.

12. The T-cell receptor of claim 4 , wherein the α subunit consists of the amino acid sequence of SEQ ID NO: 3.

13. The T-cell receptor of claim 4 , wherein the β subunit has at least 99% sequence identity to SEQ ID NO:7.

14. The T-cell receptor of claim 4 , wherein the β subunit consists of the amino acid sequence of SEQ ID NO: 7.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2009
From: ECONOMOU, JAMES S.; RIBAS, ANTONI
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 022648/0798 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2009
From: YANG, LILI; BALTIMORE, DAVID; WANG, PIN
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 022648/0885 →
Continuity (2)
Provisional Application 60848207 · Sep 29, 2006
Related Publication 20080199424A1 · Aug 21, 2008